Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei.
about
Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513.Shifts in oxidation states of cerium oxide nanoparticles detected inside intact hydrated cells and organellesEnhancement of natural background gamma-radiation dose around uranium microparticles in the human bodyMotexafin gadolinium enhances the efficacy of aminolevulinic acid mediated-photodynamic therapy in human glioma spheroids.Synthesis and biological evaluation of a class of mitochondrially-targeted gadolinium(III) agents.Motexafin gadolinium: a novel radiosensitizer for brain tumors.Microbeam radiosurgery using synchrotron-generated submillimetric beams: a new tool for the treatment of brain disorders.High mitochondrial accumulation of new gadolinium(III) agents within tumour cells.Interventional MRI-guided local delivery of agents into swine bile duct walls using MR-compatible needle-integrated balloon catheter system.Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors.Specific molecular and cellular events induced by irradiated X-ray photoactivatable drugs raise the problem of co-toxicities: particular consequences for anti-cancer synchrotron therapy.Opportunistic dose amplification for proton and carbon ion therapy via capture of internally generated thermal neutrons
P2860
Q27310843-B534C4F3-0939-4114-AC25-E41CE72980AAQ28396653-A340D69A-D6CD-4E7A-AC35-8AED2B21AD07Q29037479-A449A502-78B9-45AE-AD69-0F089435C27FQ33975357-0C290440-4701-4DD3-8A9B-D7347E229AEEQ35343010-8D8B9827-E430-4435-89AD-C3917F33F6D9Q36842747-E233786F-556C-436D-9D56-CF54ADE49D66Q37810795-AE249894-FA9C-42E4-9159-F3B04BC7FEE5Q39042049-C16B20C0-0212-4723-B2C4-02CC5F2CACD7Q40977368-14E3FADB-1914-425C-8C4C-6F21C481920EQ41830375-7BB98178-AF9D-4F33-A597-79660FB00814Q43514065-A4762CB0-11B0-4C0F-86D2-002988A63289Q58618176-035F2E8B-C8A6-4FE2-B574-F87CD847031B
P2860
Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei.
@ast
Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei.
@en
Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei.
@nl
type
label
Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei.
@ast
Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei.
@en
Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei.
@nl
prefLabel
Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei.
@ast
Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei.
@en
Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei.
@nl
P2093
P1476
Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei
@en
P2093
Bradley H Frazer
Deepika Rajesh
François Estève
John F Fowler
Judith M Ford
Mary K Gilles
Matthew J Daniels
Robert J Erhardt
Robert L Conhaim
Steven P Howard
P304
P356
10.1158/1078-0432.CCR-05-0743
P407
P577
2006-01-01T00:00:00Z